NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/18/2025
Back to search
Official data from USPTO
E5 PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/19/2025
Trademark type
Word
Nice classes
5
Filing date
12/05/2018
Registration date
12/24/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2025
Last transaction
06/19/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
11/17/2017
First use in commerce
11/17/2017
Drawing code
4
Owner type
16
Owner location
Boca Raton, FL
Examiner
COUGHLAN, REBECCA
Current location
Historical data usage
Holders and representatives
Holders
e5 Pharma, LLC
Representatives
Clark Sullivan SULLIVAN IP SOLUTIONS
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human health productspharmaceutical products for controlling and reducing seizures
Publications
History of USPTO decisions and trademark events.
24 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2025
ES8R
TEAS SECTION 8 RECEIVED
03/16/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2019
PUBO
PUBLISHED FOR OPPOSITION
10/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/27/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/27/2019
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
03/12/2019
ALIE
ASSIGNED TO LIE
03/12/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/12/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/12/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/12/2019
DOCK
ASSIGNED TO EXAMINER
03/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/22/2018
Continuous trademark protection
Get notified about every new filing that threatens E5 PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.